Article Details
Retrieved on: 2022-03-16 03:34:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
YOKOHAMA, Japan, March 16, 2022--CoreTissue BioEngineering Inc., a medical device company, was accepted into Johnson & Johnson Innovation - JPOD ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here